For Healthcare Providers
Drug-Free Opioid Withdrawal Device

Introducing Bridge™

Don't let the fear of withdrawal stop you from seeking recovery.

The first FDA-cleared medical device for the reduction of opioid withdrawal symptoms.*

Find a Provider Download Brochure
Product Details Additional Information

Clinically Proven
Demonstrated in a 73-patient clinical study to reduce withdrawal symptoms1

Fast
May provide relief from opioid withdrawal symptoms, in as soon as 20 minutes1

Effective
Patients experienced an 85% reduction2 in symptoms of opioid withdrawal within 1 hour1

Safe
No reported side effects with minimal risks during device placement3

Comfortable
Device fits comfortably behind the ear and provides five days of continuous relief

Treatment Progression
Quick relief supports effective progression to next phase of recovery1

See What Others Are Saying About Bridge

How Does Bridge Work?

  • Bridge is a small electrical nerve stimulator device that contains a battery-powered chip and wires that are applied behind the ear.


  • Bridge sends gentle electrical impulses to nerves around your ear, which are transmitted to the brain, reducing withdrawal symptoms.


  • Bridge requires a prescription and is applied by a qualified healthcare professional in a short, non-surgical, in-office procedure.

Who Can Bridge Help?

Bridge is designed to help people‡ with opioid withdrawal symptoms. Opioid withdrawal symptoms have been found to occur while:


  • Initiating treatment


  • Tapering off medication-assisted treatment (MAT)


  • Tapering off opioid therapy

Ask your doctor today about how Bridge can help you.

Find Nearby Provider
Download Brochure
      *Bridge is FDA cleared for the treatment of opioid withdrawal symptoms only. It is not intended to be used to directly treat opioid use disorders.
      1Miranda A, Taca A. Neuromodulation with percutaneous electrical nerve field stimulation is associated with reduction in signs and symptoms of opioid withdrawal: a multisite, retrospective assessment [published correction appears in Am J Drug Alcohol Abuse. 2018;44(4):498]. Am J Drug Alcohol Abuse. 2018;44(1):56‐63. doi:10.1080/00952990.2017.1295459
      2Percentage reduction is based upon Clinical Opioid Withdrawal Scale scores monitored on 73 patients suffering from opioid withdrawal symptoms.
      3Roberts, Arthur et al. “Minimal adverse effects profile following implantation of periauricular percutaneous electrical nerve field stimulators: a retrospective cohort study.” Medical devices (Auckland, N.Z.) vol. 9 389-393. 3 Nov. 2016, doi:10.2147/MDER.S107426
      ‡Do not use if you have hemophilia, psoriasis vulgaris, or a cardiac pacemaker.


      Federal (USA) law restricts this device to sale by or on the order of a physician. See instructions for use for full prescribing information, including indications, contraindications, warnings, and precautions.


      PLCO-007289/PLM-15026A-0424